Strategy Asset Managers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-441
| Closed | -$314K | – | 263 |
|
|
2024
Q4 | $314K | Sell |
441
-107
| -20% | -$76.2K | 0.06% | 198 |
|
|
2024
Q3 | $576K | Buy |
+548
| New | +$576K | 0.11% | 139 |
|
|
2024
Q1 | – | Sell |
-678
| Closed | -$595K | – | 253 |
|
|
2023
Q4 | $595K | Sell |
678
-89
| -12% | -$78.2K | 0.14% | 108 |
|
|
2023
Q3 | $631K | Buy |
+767
| New | +$631K | 0.17% | 102 |
|
|
2021
Q1 | – | Sell |
-988
| Closed | -$477K | – | 275 |
|
|
2020
Q4 | $477K | Sell |
988
-447
| -31% | -$216K | 0.11% | 140 |
|
|
2020
Q3 | $803K | Buy |
1,435
+1,042
| +265% | +$583K | 0.21% | 89 |
|
|
2020
Q2 | $245K | Buy |
+393
| New | +$245K | 0.07% | 199 |
|
|
2019
Q2 | – | Sell |
-42
| Closed | -$17K | – | 181 |
|
|
2019
Q1 | $17K | Buy |
+42
| New | +$17K | ﹤0.01% | 182 |
|
|
2018
Q4 | – | Sell |
-1,092
| Closed | -$441K | – | 130 |
|
|
2018
Q3 | $441K | Hold |
1,092
| – | – | 0.09% | 114 |
|
|
2018
Q2 | $377K | Buy |
+1,092
| New | +$377K | 0.08% | 114 |
|
|
2018
Q1 | – | Sell |
-1,092
| Closed | -$411K | – | 137 |
|
|
2017
Q4 | $411K | Buy |
+1,092
| New | +$411K | 0.08% | 115 |
|
|
2016
Q3 | – | Sell |
-6,187
| Closed | -$2.16M | – | 141 |
|
|
2016
Q2 | $2.16M | Sell |
6,187
-44
| -0.7% | -$15.4K | 0.49% | 72 |
|
|
2016
Q1 | $2.25M | Buy |
6,231
+220
| +4% | +$79.3K | 0.51% | 72 |
|
|
2015
Q4 | $3.26M | Buy |
6,011
+45
| +0.8% | +$24.4K | 0.74% | 38 |
|
|
2015
Q3 | $2.78M | Hold |
5,966
| – | – | 0.67% | 43 |
|
|
2015
Q2 | $3.04M | Sell |
5,966
-12
| -0.2% | -$6.12K | 0.68% | 43 |
|
|
2015
Q1 | $2.7M | Buy |
+5,978
| New | +$2.7M | 0.59% | 56 |
|